Evodenoson

Overview

Evodenoson is a selective agonist of the A 2A adenosine receptor . Evodenoson’s primary actions include reducing inflammatory responses, decreasing intestinal fluid secretion, edema, tissue damage, and neutrophil infiltration induced by Clostridium difficile toxin A. Evodenoson’s protective effect is achieved by reducing myeloperoxidase (MPO) and adenosine deaminase (ADA) activities, and by lowering the production of tumor necrosis factor-alpha (TNF-α).

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Infection | Products > Signaling Pathways > Adenosine Receptor

Product Information

• Catalog No.: HY-105017
• CAS No.: 844873-47-8
• Molecular Formula: C23H29N7O6
• Molecular Weight: 499.52
• Purity: 99.94%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: 1 mg/mL (2.00 mM); Clear solution; Need ultrasonic
• Availability: In-stock

Source

Original product source